Explaining diabetes, its various treatment options, and what the future may have in store for this disease.

Major U.S. automakers trade at historically low valuations despite huge sales success and spectacular profits. How can this be? The Motley Fool’s John Rosevear and Sean O’Reilly dive in.

Coinciding nicely with National Bourbon Day, we look at the latest developments in the alcohol industry from a spin-off at Constellation Brands to the incredible growth of new “beer” categories and a controversial offering from SodaStream.

There’s more to a fund than just its name. Here’s how to do deep due diligence into the mutual funds in your retirement account.

For video highlights of our Fool Fest Digital Pass go to http://digitalpass.fool.com/focus

The video game industry is booming thanks to strong consumer demand, the rise of Esports, and the franchise extensions into other forms of media. Analyst David Kretzman joins us to talk about some trends to watch and his favorite company in the space. 

Elon Musk’s pet project SpaceX is still a private company, but would you invest in it if the situation was otherwise?

What cancer drug companies came out ahead at this weekend's ASCO conference and a closer look at Biogen's recent disappointment.

With massive, multi-billion dollar valuations, unicorn start-ups Uber and Lyft are locked in an intense, sometimes controversial, race to become the ride of choice for users all over the world. We look at the stories behind each company and how their expansion plans are pushing them into complementary industries like delivery and driverless cars, often with the help of industry incumbents. 

Understanding the ins and outs of individual retirement accounts can give your retirement savings a jump-start. 

We discuss the P/E ratio and what it implies. Premium analyst Simon Erickson joins the show to explain how some Fools’ mentality towards the metric is different than most investors.